Double the Shares, Double the Joy — Thyrocare Tech Rolls Out Bonus Shares and Dividend Amid Strong Q2 Performance

Image Source: The Economic Times

Thyrocare Technologies Ltd announced an interim dividend of Rs 7 per share and approved a 2:1 bonus share issuance. The company posted a consolidated operating revenue of Rs 2.17 billion and net profit of Rs 479.9 million for the September quarter 2025, reflecting robust growth and shareholder rewards.

Thyrocare Technologies Ltd, a leading diagnostic and preventive healthcare provider, announced key corporate actions and quarterly earnings that reinforce its growth trajectory and commitment to shareholders. At the board meeting held recently, the company approved an interim dividend of Rs 7 per equity share alongside a landmark bonus share issuance in the ratio of 2:1. This move marks the first bonus share offering by Thyrocare, rewarding shareholders with two additional shares for every share held.

Dividend Declaration and Bonus Shares

The interim dividend of Rs 7 per share signifies a steady payout, following the company's tradition of rewarding investors with attractive dividends over the years.

The bonus shares issuance of 2:1 is a strategic step to enhance shareholder value, coinciding with the company’s silver jubilee and upcoming festive season celebrations, aimed at broadening equity base and investor goodwill.

Quarterly Financial Performance

Thyrocare reported consolidated operating revenue of Rs 2.17 billion for the September quarter of 2025, marking a healthy year-on-year growth of approximately 22%.

Consolidated net profit stood strong at Rs 479.9 million, reflecting a resilient bottom line amid evolving market dynamics.

Earnings before interest and taxes (EBIT) expanded significantly, showing margin improvement driven by operational efficiencies and higher service demand.

Market Impact and Outlook

The company’s stock responded positively to the announcements, maintaining steady momentum with a promising outlook from analysts projecting continued growth in revenue and profitability.

Thyrocare’s strategic focus on diagnostic innovations and preventive care services is expected to sustain its competitive edge, supported by favorable industry trends and increasing healthcare awareness.

The September quarter results and bold corporate actions underscore Thyrocare Technologies’ robust financial health and commitment to rewarding its shareholders while fostering long-term value creation.

Sources: NDTV Profit, CNBC TV18, Moneycontrol, BSE filings.

Stay Ahead – Explore Now! From Buenos Aires to India’s Kitchens: Record Soyoil Import Deal Marks Strategic Shift

STORIES YOU MAY LIKE

Image Source: Hannah Meng

WOW STORY OF THE DAY From Near-Deletion to Global Obsession: How Notion Rebuilt Its Future

Image Source: SugerMint

Silver Stop: Aditya Birla Sun Life Pauses Fresh ETF Subscriptions Amid Market Crunch

Image Source: fundacioenllac.cat

Sula’s Q2 Revenue Dips 1.1% — But The Wine Tourism Buzz Is Unstoppable

Image Source: Times of India

Insuring Growth: ICICI Lombard’s ₹8.2 Billion Profit Fueled by Rising Premiums

Big Deals, Big Moves: CCI Endorses Vedanta’s Jaiprakash Acquisition and Capgemini’s Cloud Leap

Image Source: Press Trust of India

Raising the Bar: UGRO Capital Plans ₹300 Crore Fundraise for Expansion

Image Source: dnaindia.com

India Post to Resume All Services to USA from October 15 Under New Customs Framework

Top Searches

Suggestions

Double the Shares, Double the Joy — Thyrocare Tech Rolls Out Bonus Shares and Dividend Amid Strong Q2 Performance

STORIES YOU MAY LIKE

Live Blogs

Top Stories

Double the Shares, Double the Joy — Thyrocare Tech Rolls Out Bonus Shares and Dividend Amid Strong Q2 Performance

STORIES YOU MAY LIKE

Subscribe to receive the day's headlines from WOWNEWS 24X7 straight in your inbox

Live Blogs

Top Stories